WallStreetZenWallStreetZen

NYSE: CLVT
Clarivate PLC Stock

$5.41+0.07 (+1.31%)
Updated Jun 14, 2024
CLVT Price
$5.41
Fair Value Price
N/A
Market Cap
$3.62B
52 Week Low
$5.27
52 Week High
$10.03
P/E
-3.28x
P/B
0.61x
P/S
1.89x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.62B
Earnings
-$1.03B
Gross Margin
65.9%
Operating Margin
-29.08%
Profit Margin
-42.2%
Debt to Equity
1.12
Operating Cash Flow
$693M
Beta
1.02
Next Earnings
Aug 1, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CLVT Overview

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

Zen Score

Industry Average (35)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CLVT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLVT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLVT is good value based on its book value relative to its share price (0.61x), compared to the US Information Technology Services industry average (4.42x)
P/B vs Industry Valuation
CLVT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CLVT due diligence checks available for Premium users.

Be the first to know about important CLVT news, forecast changes, insider trades & much more!

CLVT News

Valuation

CLVT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.28x
Industry
26.79x
Market
30.51x

CLVT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.61x
Industry
4.42x
CLVT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLVT's financial health

Profit margin

Revenue
$621.2M
Net Income
-$75.0M
Profit Margin
-15.1%
CLVT's Earnings (EBIT) of -$762.10M... subscribe to Premium to read more.
Interest Coverage Financials
CLVT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$12.5B
Liabilities
$6.6B
Debt to equity
1.12
CLVT's short-term liabilities ($1.61B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLVT's long-term liabilities ($5.00B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLVT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLVT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$176.2M
Investing
-$64.4M
Financing
-$95.2M
CLVT's operating cash flow ($692.90M)... subscribe to Premium to read more.
Debt Coverage Financials

CLVT vs Information Technology Service Stocks

TickerMarket Cap1d %P/EP/B
CLVT$3.62B+1.31%-3.28x0.61x
CNXC$3.84B-0.90%12.15x0.94x
AUR$3.91B+0.80%-4.67x2.11x
DXC$3.19B-4.60%38.80x1.14x
ASGN$4.04B-1.54%20.20x2.17x

Clarivate Stock FAQ

What is Clarivate's quote symbol?

(NYSE: CLVT) Clarivate trades on the NYSE under the ticker symbol CLVT. Clarivate stock quotes can also be displayed as NYSE: CLVT.

If you're new to stock investing, here's how to buy Clarivate stock.

What is the 52 week high and low for Clarivate (NYSE: CLVT)?

(NYSE: CLVT) Clarivate's 52-week high was $10.03, and its 52-week low was $5.27. It is currently -46.06% from its 52-week high and 2.66% from its 52-week low.

How much is Clarivate stock worth today?

(NYSE: CLVT) Clarivate currently has 668,237,610 outstanding shares. With Clarivate stock trading at $5.41 per share, the total value of Clarivate stock (market capitalization) is $3.62B.

Clarivate stock was originally listed at a price of $10.05 in Sep 7, 2018. If you had invested in Clarivate stock at $10.05, your return over the last 5 years would have been -46.17%, for an annualized return of -11.65% (not including any dividends or dividend reinvestments).

How much is Clarivate's stock price per share?

(NYSE: CLVT) Clarivate stock price per share is $5.41 today (as of Jun 14, 2024).

What is Clarivate's Market Cap?

(NYSE: CLVT) Clarivate's market cap is $3.62B, as of Jun 16, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Clarivate's market cap is calculated by multiplying CLVT's current stock price of $5.41 by CLVT's total outstanding shares of 668,237,610.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.